Fennec Pharmaceuticals Inc. (FENC) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 15.11M | 13.78M | 12.46M | 9.65M | 8.75M | 7.92M | 6.97M | 7.26M | 25.38M | 9.73M | 6.51M | 3.33M | 1.68M | 1.53M | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 72.64% | 73.84% | 78.69% | 32.91% | -65.52% | -18.59% | 7.05% | 118.41% | 1413.24% | 534.2% | - | - | - | - | - | - | - | -100% | - | - |
| Cost of Goods Sold | 570K | 1.76M | 660K | 967K | 373K | 669K | 1.36M | 608K | 550K | 685K | 331K | 148K | 95K | 86K | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 3.77% | 12.8% | 5.3% | 10.02% | 4.26% | 8.44% | 19.46% | 8.37% | 2.17% | 7.04% | 5.08% | 4.45% | 5.66% | 5.6% | - | - | - | - | - | - |
| Gross Profit | 14.54M | 12.01M | 11.8M | 8.69M | 8.38M | 7.26M | 5.62M | 6.65M | 24.83M | 9.05M | 6.18M | 3.18M | 1.58M | 1.45M | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 96.23% | 87.2% | 94.7% | 89.98% | 95.74% | 91.56% | 80.54% | 91.63% | 97.83% | 92.96% | 94.92% | 95.55% | 94.34% | 94.4% | - | - | - | - | - | - |
| Gross Profit Growth % | 73.53% | 65.56% | 110.11% | 30.52% | -66.25% | -19.82% | -9.17% | 109.44% | 1469.34% | 524.57% | - | - | - | - | - | - | - | -100% | - | - |
| Operating Expenses | 14.66M | 14.59M | 12M | 11.42M | 9.2M | 8.21M | 10.84M | 11.69M | 11.08M | 10.87M | 7.2M | 7.84M | 6.85M | 7.67M | 7.9M | 5.01M | 3.55M | 4.21M | 4.17M | 3.92M |
| OpEx % of Revenue | 97.01% | 105.92% | 96.32% | 118.29% | 105.12% | 103.66% | 155.43% | 161.02% | 43.68% | 111.64% | 110.53% | 235.88% | 408.59% | 499.67% | - | - | - | - | - | - |
| Selling, General & Admin | 14.61M | 14.55M | 11.96M | 11.31M | 9.09M | 8.14M | 10.72M | 11.54M | 11.08M | 10.84M | 7.19M | 7.83M | 6.85M | 7.47M | 7.05M | 3.88M | 2.11M | 3.68M | 2.93M | 3.12M |
| SG&A % of Revenue | 96.69% | 105.59% | 95.99% | 117.18% | 103.9% | 102.71% | 153.74% | 158.85% | 43.67% | 111.31% | 110.35% | 235.64% | 408.35% | 486.45% | - | - | - | - | - | - |
| Research & Development | 49K | 20K | 29K | 107K | 94K | 50K | 97K | 157K | 3K | 32K | 12K | 8K | 4K | 117K | 846K | 1.13M | 1.44M | 523K | 1.24M | 800K |
| R&D % of Revenue | 0.32% | 0.15% | 0.23% | 1.11% | 1.07% | 0.63% | 1.39% | 2.16% | 0.01% | 0.33% | 0.18% | 0.24% | 0.24% | 7.62% | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 26K | 12K | 0 | 13K | 25K | 21K | 0 | 0 | 0 | 0 | 0 | 0 | 86K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -119K | -2.58M | -201K | -2.73M | -821K | -959K | -5.22M | -5.04M | 13.74M | -1.82M | -1.02M | -4.67M | -5.27M | -6.13M | -7.9M | -5.01M | -3.55M | -4.21M | -4.17M | -3.92M |
| Operating Margin % | -0.79% | -18.73% | -1.61% | -28.31% | -9.38% | -12.1% | -74.89% | -69.39% | 54.16% | -18.67% | -15.61% | -140.33% | -314.25% | -399.67% | - | - | - | - | - | - |
| Operating Income Growth % | 85.51% | -169.03% | 96.15% | 45.78% | -105.97% | 47.25% | -413.57% | -7.99% | 360.78% | 70.37% | 87.13% | 6.85% | -48.62% | -45.83% | -89.29% | -27.78% | 27.97% | -25.73% | 28.78% | 19.09% |
| EBITDA | -93K | -2.55M | -175K | -2.71M | -795K | -933K | -5.2M | -5.01M | 14.47M | -1.75M | -939K | -4.72M | -5.22M | -6.11M | -7.83M | -5.01M | -3.54M | -4.2M | -4.17M | -3.99M |
| EBITDA Margin % | -0.62% | -18.54% | -1.4% | -28.05% | -9.08% | -11.77% | -74.53% | -69.03% | 57% | -17.96% | -14.41% | -141.89% | -311.15% | -398.24% | - | - | - | - | - | - |
| EBITDA Growth % | 88.3% | -173.74% | 96.63% | 46% | -105.5% | 46.62% | -453.57% | -6.25% | 377.23% | 71.41% | 88.02% | 5.92% | -47.44% | -45.58% | -88.12% | -25.63% | 25.16% | -25.49% | 24.33% | 17.09% |
| D&A (Non-Cash Add-back) | 26K | 26K | 26K | 25K | 26K | 26K | 25K | 26K | 723K | 70K | 0 | -52K | 52K | 0 | 64K | 0 | 7K | 8K | 8K | 0 |
| EBIT | 208K | -4.37M | -52K | -2.56M | -573K | -654K | -4.71M | -4.51M | 13.87M | -1.77M | -1.01M | -4.62M | -5.25M | -6.11M | -7.97M | -5.01M | -3.64M | -4.37M | -4.13M | -3.99M |
| Net Interest Income | 332K | -80K | -434K | -443.18K | -367.88K | -592K | -509K | -497K | -837K | -800K | -754K | -793.34K | -689K | -661K | -95K | -47.59K | -49K | 12.96K | -41.71K | 3K |
| Interest Income | 339K | 228K | 152K | 173.82K | 235.29K | 374K | 516K | 570K | 197K | 115K | 102K | 116.52K | 109K | 153K | 24K | 8.92K | 9K | 12.96K | 12.91K | 12K |
| Interest Expense | 7K | 308K | 586K | 617K | 603.17K | 966K | 1.02M | 1.07M | 1.03M | 915K | 856K | 909.86K | 798K | 815.23K | 119K | 56.51K | 58K | - | 54.63K | 9K |
| Other Income/Expense | 320K | -2.1M | -437K | -420K | -344K | -661K | -512K | -514K | -906K | -864K | -850K | -778K | -782K | -722K | -190K | -63K | -150K | -220K | -12K | -81K |
| Pretax Income | 201K | -4.68M | -638K | -3.15M | -1.17M | -1.62M | -5.74M | -5.55M | 12.84M | -2.68M | -1.87M | -5.44M | -6.05M | -6.86M | -8.09M | -5.07M | -3.7M | -4.43M | -4.18M | -4M |
| Pretax Margin % | 1.33% | -33.98% | -5.12% | -32.66% | -13.31% | -20.44% | -82.23% | -76.47% | 50.59% | -27.55% | -28.66% | -163.73% | -360.88% | -446.71% | - | - | - | - | - | - |
| Income Tax | 0 | 106K | 0 | 0 | 0 | 365K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -2.26% | 0% | 0% | 0% | -22.53% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 201K | -4.79M | -638K | -3.15M | -1.17M | -1.99M | -5.74M | -5.55M | 12.84M | -2.68M | -1.87M | -5.44M | -6.05M | -6.86M | -8.09M | -5.07M | -3.7M | -4.43M | -4.18M | -4M |
| Net Margin % | 1.33% | -34.75% | -5.12% | -32.66% | -13.31% | -25.05% | -82.23% | -76.47% | 50.59% | -27.55% | -28.66% | -163.73% | -360.88% | -446.71% | - | - | - | - | - | - |
| Net Income Growth % | 117.25% | -141.16% | 88.88% | 43.24% | -109.08% | 25.99% | -207.18% | -2% | 312.11% | 60.89% | 76.92% | -7.33% | -63.74% | -54.89% | -93.29% | -26.77% | 21.91% | -36.72% | 32.5% | 17.42% |
| Net Income (Continuing) | 201K | -4.79M | -638K | -3.15M | -1.17M | -1.99M | -5.74M | -5.55M | 12.84M | -2.68M | -1.87M | -5.44M | -6.05M | -6.86M | -8.09M | -5.07M | -3.7M | -4.43M | -4.18M | -4M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.01 | -0.17 | -0.02 | -0.12 | -0.04 | -0.06 | -0.21 | -0.20 | 0.41 | -0.10 | -0.07 | -0.21 | -0.29 | -0.30 | -0.31 | -0.19 | -0.15 | -0.17 | -0.16 | -0.15 |
| EPS Growth % | 113.27% | -196.68% | 89.1% | 40% | -110.29% | 42.7% | -200% | 4.76% | 241.38% | 66.67% | 77.42% | -10.53% | -93.33% | -76.47% | -93.75% | -26.67% | 16.67% | -21.43% | 33.33% | 28.57% |
| EPS (Basic) | 0.01 | -0.17 | -0.02 | -0.12 | -0.04 | -0.07 | -0.21 | -0.20 | 0.47 | -0.10 | -0.07 | -0.21 | -0.29 | -0.30 | -0.31 | -0.19 | -0.15 | -0.17 | -0.16 | -0.15 |
| Diluted Shares Outstanding | 35.55M | 31.18M | 27.89M | 27.66M | 27.58M | 27.46M | 27.37M | 27.3M | 31.09M | 26.83M | 26.46M | 26.46M | 26.56M | 26.36M | 26.11M | 26.05M | 26.02M | 26.01M | 26.01M | 26M |
| Basic Shares Outstanding | 34.34M | 31.18M | 27.89M | 27.66M | 27.58M | 27.46M | 27.37M | 27.3M | 27.05M | 26.83M | 26.46M | 26.46M | 26.56M | 26.36M | 26.09M | 26.05M | 26.02M | 26.01M | 26.01M | 26M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |